Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2025-12-24 @ 10:52 PM
NCT ID:
NCT02370069
Eligibility Criteria:
Inclusion Criteria:
* Males and females of 18 years of age or older at the time of the vaccination
* Severe chronic kidney disease (Stage 4 and 5)
Exclusion Criteria:
* immunization with PPV23 within the last year
* any confirmed or suspected immunodeficiency condition, including human immunodeficiency virus (HIV) infection, haematological malignancy, or a congenital immunodeficiency
* history of allergic disease or reactions likely to be exacerbated by any component of the vaccine
* history of allergic disease likely to be stimulated by the vaccination
* history or records of immunosuppressive therapy (with the exception of topical corticosteroids) for more than 14 days and within 6 months of vaccination
* history or evidence of administration of immunoglobulins and/or any blood products during the study period or within the three months preceding the study vaccine
* use of any other investigational or non-registered drug or vaccine during the study period or within 30 days preceding the study vaccine
* administration of a vaccine during the period starting one month before the dose of vaccine and ending one month after
* pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02370069
Study Brief:
Protocol Section:
NCT02370069